ipilimumab
bms
[]
 presenting the til trial at #esmo22 presidential symposium#1. exciting data. will they be practice-changing? 
Medical Oncologist, GI cancers @nki_nl neoadjuvant #immunotherapy #cancerresearch. Opinions my own